TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T30985	Histamine H2 receptor	D04USC	Ergotidine	Approved	774	C5H9N3	111.15	C1=C(NC=N1)CCN	Ki = 50118.72 nM	Poor binder
T30985	Histamine H2 receptor	B3DFI4	Tert-butyl (2R)-2-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazine-1-carbonyl]pyrrolidine-1-carboxylate	Investigative	44304316	C27H39N3O5	485.6	CC(C)(C)OC(=O)N1CCC[C@@H]1C(=O)N2CCN(CC2)CCCOC3=CC=C(C=C3)C(=O)C4CC4	Ki = 50118.72 nM	Poor binder
T30985	Histamine H2 receptor	B3MDF6	4-[3-(4-Propionylphenoxy)propyl]-1-piperazinecarboxylic acid ethyl ester	Investigative	44304475	C19H28N2O4	348.4	CCC(=O)C1=CC=C(C=C1)OCCCN2CCN(CC2)C(=O)OCC	Ki = 56234.13 nM	Poor binder
T30985	Histamine H2 receptor	B3U9NE	4'-(3-Pyrrolizinopropoxy)biphenyl-4-carbonitrile	Investigative	18672441	C20H22N2O	306.4	C1CCN(C1)CCCOC2=CC=C(C=C2)C3=CC=C(C=C3)C#N	Ki = 67608.3 nM	Poor binder
T30985	Histamine H2 receptor	B3V5OE	1-[4-[3-[4-(Methylsulfonyl)piperazino]propoxy]phenyl]-1-hexanone	Investigative	44304978	C20H32N2O4S	396.5	CCCCCC(=O)C1=CC=C(C=C1)OCCCN2CCN(CC2)S(=O)(=O)C	Ki = 83176.38 nM	Poor binder
T30985	Histamine H2 receptor	B4T8SX	(2R)-2-Amino-1-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-3-(1,3-thiazol-2-yl)propan-1-one	Investigative	44304311	C23H30N4O3S	442.6	C1CC1C(=O)C2=CC=C(C=C2)OCCCN3CCN(CC3)C(=O)[C@@H](CC4=NC=CS4)N	Ki = 97723.72 nM	Poor binder
T30985	Histamine H2 receptor	B4TC0A	Ethyl 4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazine-1-carboxylate	Investigative	44304090	C20H28N2O4	360.4	CCOC(=O)N1CCN(CC1)CCCOC2=CC=C(C=C2)C(=O)C3CC3	Ki = 79432.82 nM	Poor binder
T30985	Histamine H2 receptor	B7ORB1	1-[4-[3-[4-(Cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-(methylamino)ethanone	Investigative	44304067	C20H29N3O3	359.5	CNCC(=O)N1CCN(CC1)CCCOC2=CC=C(C=C2)C(=O)C3CC3	Ki = 79432.82 nM	Poor binder
T30985	Histamine H2 receptor	B7R3OU	(2R)-2-Amino-1-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]butan-1-one	Investigative	44304211	C21H31N3O3	373.5	CC[C@H](C(=O)N1CCN(CC1)CCCOC2=CC=C(C=C2)C(=O)C3CC3)N	Ki = 100000 nM	Poor binder
T30985	Histamine H2 receptor	B8J9VN	1-[4-[3-[4-(Pyridine-3-carbonyl)piperazin-1-yl]propoxy]phenyl]hexan-1-one	Investigative	44304378	C25H33N3O3	423.5	CCCCCC(=O)C1=CC=C(C=C1)OCCCN2CCN(CC2)C(=O)C3=CN=CC=C3	Ki = 60255.96 nM	Poor binder
T30985	Histamine H2 receptor	B9OP0K	1-[4-[3-[4-(Cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-2-[(2R)-pyrrolidin-2-yl]ethanone	Investigative	44304332	C23H33N3O3	399.5	C1C[C@@H](NC1)CC(=O)N2CCN(CC2)CCCOC3=CC=C(C=C3)C(=O)C4CC4	Ki = 89125.09 nM	Poor binder
T30985	Histamine H2 receptor	BB05UQ	Cyclopropyl(4-(3-(4-((2r)-2-(isopropylamino)propanoyl)-1-piperazinyl)propoxy)phenyl)methanone	Investigative	44304056	C23H35N3O3	401.5	C[C@H](C(=O)N1CCN(CC1)CCCOC2=CC=C(C=C2)C(=O)C3CC3)NC(C)C	Ki = 50118.72 nM	Poor binder
T30985	Histamine H2 receptor	BD0Y9J	4-[3-[4-(4-Pyridinyl)phenoxy]propyl]piperazine-1-carboxylic acid ethyl ester	Investigative	44335222	C21H27N3O3	369.5	CCOC(=O)N1CCN(CC1)CCCOC2=CC=C(C=C2)C3=CC=NC=C3	Ki = 57543.99 nM	Poor binder
T30985	Histamine H2 receptor	BJ40GP	(2R)-2-Amino-1-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-3-(1H-imidazol-5-yl)propan-1-one	Investigative	44304719	C23H31N5O3	425.5	C1CC1C(=O)C2=CC=C(C=C2)OCCCN3CCN(CC3)C(=O)[C@@H](CC4=CN=CN4)N	Ki = 89125.09 nM	Poor binder
T30985	Histamine H2 receptor	BKN1R4	4-[3-(4'-Methoxy-4-biphenylyloxy)propyl]piperazine-1-carboxylic acid ethyl ester	Investigative	44335350	C23H30N2O4	398.5	CCOC(=O)N1CCN(CC1)CCCOC2=CC=C(C=C2)C3=CC=C(C=C3)OC	Ki = 100000 nM	Poor binder
T30985	Histamine H2 receptor	BL9QI4	(2R)-2-Amino-1-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-4,4-dimethylpentan-1-one	Investigative	44304357	C24H37N3O3	415.6	CC(C)(C)C[C@H](C(=O)N1CCN(CC1)CCCOC2=CC=C(C=C2)C(=O)C3CC3)N	Ki = 57543.99 nM	Poor binder
T30985	Histamine H2 receptor	BM15XS	4-[3-[4-[N-(Tert-Butoxycarbonyl)-D-alanyl]piperazino]propoxy]phenylcyclopropyl ketone	Investigative	44304752	C25H37N3O5	459.6	C[C@H](C(=O)N1CCN(CC1)CCCOC2=CC=C(C=C2)C(=O)C3CC3)NC(=O)OC(C)(C)C	Ki = 83176.38 nM	Poor binder
T30985	Histamine H2 receptor	BM78SH	4-[3-[4-(3-Thienyl)phenoxy]propyl]piperazine-1-carboxylic acid ethyl ester	Investigative	44335172	C20H26N2O3S	374.5	CCOC(=O)N1CCN(CC1)CCCOC2=CC=C(C=C2)C3=CSC=C3	Ki = 97723.72 nM	Poor binder
T30985	Histamine H2 receptor	BN9XC0	Ethyl 4-[3-[4-(1H-imidazol-5-yl)phenoxy]propyl]piperazine-1-carboxylate	Investigative	44335428	C19H26N4O3	358.4	CCOC(=O)N1CCN(CC1)CCCOC2=CC=C(C=C2)C3=CN=CN3	Ki = 69183.1 nM	Poor binder
T30985	Histamine H2 receptor	BO2I5Y	1-{4-[3-((S)-3-Amino-pyrrolidin-1-yl)-propoxy]-phenyl}-ethanone	Investigative	44334521	C15H22N2O2	262.35	CC(=O)C1=CC=C(C=C1)OCCCN2CC[C@@H](C2)N	Ki = 50000 nM	Poor binder
T30985	Histamine H2 receptor	BQDY04	(3R)-3-Amino-4-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-4-oxobutanenitrile	Investigative	44304003	C21H28N4O3	384.5	C1CC1C(=O)C2=CC=C(C=C2)OCCCN3CCN(CC3)C(=O)[C@@H](CC#N)N	Ki = 72443.6 nM	Poor binder
T30985	Histamine H2 receptor	BSLC85	N,N-Dimethyl-4-[1-oxo-2-(2-pyrrolidin-1-ylethyl)-3,4-dihydroisoquinolin-6-yl]benzamide	Investigative	25218397	C24H29N3O2	391.5	CN(C)C(=O)C1=CC=C(C=C1)C2=CC3=C(C=C2)C(=O)N(CC3)CCN4CCCC4	Ki ~ 55000 nM	Poor binder
T30985	Histamine H2 receptor	BVEL93	(1-{(S)-1-[3-(4-Acetyl-phenoxy)-propyl]-pyrrolidin-3-ylcarbamoyl}-2-hydroxy-ethyl)-carbamic acid tert-butyl ester	Investigative	44334252	C23H35N3O6	449.5	CC(=O)C1=CC=C(C=C1)OCCCN2CC[C@@H](C2)NC(=O)[C@@H](CO)NC(=O)OC(C)(C)C	Ki = 100000 nM	Poor binder
T30985	Histamine H2 receptor	BWKY50	4-[3-(4-beta-Alanylpiperazino)propoxy]phenylcyclopropyl ketone	Investigative	10451094	C20H29N3O3	359.5	C1CC1C(=O)C2=CC=C(C=C2)OCCCN3CCN(CC3)C(=O)CCN	Ki = 100000 nM	Poor binder
T30985	Histamine H2 receptor	BWY42X	Ethyl 4-[3-[4-(3-methylbutanoyl)phenoxy]propyl]piperazine-1-carboxylate	Investigative	44304079	C21H32N2O4	376.5	CCOC(=O)N1CCN(CC1)CCCOC2=CC=C(C=C2)C(=O)CC(C)C	Ki = 69183.1 nM	Poor binder
T30985	Histamine H2 receptor	BXA2W8	Cyclopropyl-[4-[3-[4-[(2R)-pyrrolidine-2-carbonyl]piperazin-1-yl]propoxy]phenyl]methanone	Investigative	44304329	C22H31N3O3	385.5	C1C[C@@H](NC1)C(=O)N2CCN(CC2)CCCOC3=CC=C(C=C3)C(=O)C4CC4	Ki = 53703.18 nM	Poor binder
T30985	Histamine H2 receptor	BZ2RD3	(2R)-2-Amino-1-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]pentan-1-one	Investigative	44304348	C22H33N3O3	387.5	CCC[C@H](C(=O)N1CCN(CC1)CCCOC2=CC=C(C=C2)C(=O)C3CC3)N	Ki = 60255.96 nM	Poor binder
T30985	Histamine H2 receptor	D05BYD	A-304121	Investigative	9906860	C20H29N3O3	359.5	C[C@H](C(=O)N1CCN(CC1)CCCOC2=CC=C(C=C2)C(=O)C3CC3)N	Ki = 70794.58 nM	Poor binder